Evidence map›Paper›PMID 29434767›Full record

ArticleExperimental and therapeutic medicine2018

Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease.

Xiaoqin Hu, Chengwei Song, Ming Fang, Chengyan Li

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Lipids and Alzheimer's Disease.International journal of molecular sciences · 2020
    Review
  12. Modifiable Risk Factors for Alzheimer's Disease.Frontiers in aging neuroscience · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiaoqin HuDepartment of Neurology, Remnin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Chengwei SongDepartment of Neurology, The First Hospital of Yichang, The Gorges University College of Medicine, Yichang, Hubei 443000, P.R. China.
Ming FangDepartment of Neurology, The First Hospital of Yichang, The Gorges University College of Medicine, Yichang, Hubei 443000, P.R. China.
Chengyan LiDepartment of Neurology, Remnin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Wuhan University · CNYichang Central People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is associated with cognitive impairments that affect memory and executive functions. Simvastatin is a cholesterol-lowering statin drug that is used to control levels of cholesterol in the blood, particularly in cases of hypercholesterolemia, and may be used in the treatment of aneurysmal subarachnoid hemorrhage. Previous results have indicated that the apoptosis of hippocampal cells may serve a critical role in the progression of Alzheimer's disease. In the present study, it was determined whether Simvastatin inhibited the apoptosis of hippocampal cells

Indexed as

Alzheimer's diseaseapoptosishippocampal cellssimvastatin

Identifiers

PMID29434767
PMCPMC5776644
OpenAlexW2772485355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.